India-focused private equity firm Tano Capital will be investing in privately held drugmaker Windlas Biotech Ltd in its second deal this year and also the second bet in the pharmaceuticals space after marking its maiden investment in public listed Shilpa Medicare Ltd way back in 2005.Capsules unit at WindlasTano Capital ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
